Schaaf, Gerben <br/><br/>
Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.  [electronic resource] 

 -  Cancer research  Jan 2010 
 - 762-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-2532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Growth Processes--physiology<br/>Cell Line, Tumor<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Genes, ras<br/>Humans<br/>MAP Kinase Signaling System<br/>Male<br/>Membrane Proteins--biosynthesis<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Mutation<br/>NIH 3T3 Cells<br/>Phosphoproteins--biosynthesis<br/>Rhabdomyosarcoma, Alveolar--genetics<br/>Rhabdomyosarcoma, Embryonal--genetics<br/>ras Proteins--genetics